In this episode, Fred Turner, CEO of Curative, shares the journey of scaling the company from a COVID-19 testing powerhouse to a disruptive force in the commercial health plan space. He discusses Curative’s unique no-deductible model, the importance of early patient engagement, and the challenges of entering a highly regulated industry dominated by a few major players.
Fred Turner, CEO of Curative
Next Up in Becker’s Payer Issues Podcast
-
In this episode, Dr. Michael Bass, Global Medical Director, Viome, discusses how microbiome testing and personalized nutrition can help clinicians…
-
This episode recorded live at the Becker’s 11th Annual Health IT + Digital Health + RCM Conference features Chris Carmody,…
-
In this episode, Dr. Patricia Henwood, EVP, Chief Clinical Officer at Jefferson Health, discusses the health system’s approach to AI…
Comments are closed.